In recent years, the e-commerce market has developed rapidly, and many retail products have been expanding online. However, as a necessity for people ’s lives, the e-commerce road of medical products has not been smooth.
According to data released by the China Pharmaceutical (27.38, 0.62, 2.32%) Business Association, the retail market for pharmaceuticals in China was about 150 billion yuan in 2009, and it is expected to be about 173.9 billion yuan in 2011. But in 2009, the domestic online drug sales were only about 70 million yuan, accounting for 0.046% of the entire drug sales market that year. Although the online retail sales in 2010 had increased, it was just over 100 million yuan. In contrast, the sales scale of online pharmacies in the United States accounted for a very high proportion of the entire pharmaceutical circulation field, which was 20% in 2009 and nearly 30% in 2010.
It can be seen from this that the proportion of China's pharmaceutical online sales is still very small, and the development of pharmaceutical e-commerce is slow. "The reasons for the slow development of pharmaceutical e-commerce mainly include the following: First, domestic pharmaceutical e-commerce has just emerged, so there are still many imperfections in policy. Second, many fake drugs online have made consumers lose confidence in online transactions. The third is that the construction of pharmaceutical logistics is still not in place, and the development of third-party pharmaceutical logistics is in its infancy. "Guo Fanli, a researcher in the pharmaceutical industry of CIC Consulting, said in an interview with a reporter from China Sankei News.
Mo Daiqing, an analyst at the China E-Commerce Research Center, pointed out in an interview with a reporter from China Sankei News that the pharmaceutical regulatory authority has strict management of pharmaceutical sales and requires e-commerce companies that operate pharmaceuticals to obtain the "Internet Drug Trading Service Qualification Certificate" and "Internet Drug Information Service Qualification Certificate", which to a certain extent inhibits the widespread sale of drugs.
According to related reports, the Beijing Municipal Food and Drug Administration has even interviewed the heads of nine websites that have the qualification to sell drugs online, and asked them not to sell drugs illegally. The medical hall of Taobao Mall, an e-commerce giant headquartered in Hangzhou, Zhejiang, was only recently called out by the Zhejiang Provincial Food and Drug Administration for “undocumented†involvement in pharmaceutical B2C business. In fact, the reason for the rapid development of e-commerce, the lack of participation at the policy level is the main reason, but in the field of medicine, it can be seen that the relevant regulatory authorities are still cautious.
In this regard, Mo Daiqing said that because drugs are special commodities that are different from other commodities, even if the quality of the drugs is guaranteed in the production process, the drugs may become invalid or deteriorate during the transportation and storage. Consumers are extremely disadvantaged. So it requires professional medical e-commerce experience. This is the supervision of the online medical B2C market, so that it can develop in a more sound direction, and it is also a responsible behavior for the majority of consumers. Although it may inhibit the development of pharmaceutical B2C in the short term, in the long run it can urge the healthy development of pharmaceutical B2C, which is the norm for this market.
In fact, for the development of medical e-commerce, people in the industry generally hold a bullish attitude. The advantage of online pharmacies is that it has broken through geographical restrictions, and it is more convenient and faster, with lower costs and improved efficiency. "As early as 2007, the scale of the US pharmaceutical e-commerce market was nearly 170 billion US dollars. Last year, the scale of the US pharmaceutical e-commerce accounted for nearly 30% of the entire pharmaceutical circulation field. However, China's pharmaceutical e-commerce market is only a few billion and is now in It is in a budding state, so there is huge room for future development. "Guo Fanli said.
Mo Daiqing also expressed the same view. She believes that the future of medicine has the potential to become a new competitive point for B2C companies. At present, the market share of pharmaceutical B2C is not large. There is still a lot of space for medical B2C to dig. Seeing its potential, various online malls have set foot in the pharmaceutical industry. This will become a trend.
Colorlight LED Display Control System
Colorlight LED Display Control System,Colorlight Led Display Sending Card,Colorlight Sender Card,Colorlight Led Display Control System
Shenzhen Macion Optoelectronics Technology Co.,Ltd. , https://www.macion-led.com